ZNF273 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 4.174400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
5.493600E-01
Normal-vs-Stage2
4.610000E-01
Normal-vs-Stage3
1.525750E-01
Normal-vs-Stage4
9.505400E-01
Stage1-vs-Stage2
5.985200E-01
Stage1-vs-Stage3
6.288400E-02
Stage1-vs-Stage4
2.489200E-01
Stage2-vs-Stage3
7.389700E-02
Stage2-vs-Stage4
4.629800E-01
Stage3-vs-Stage4
6.103600E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
4.493600E-01
Normal-vs-AfricanAmerican
5.416600E-01
Normal-vs-Asian
2.681000E-01
Caucasian-vs-AfricanAmerican
9.072000E-01
Caucasian-vs-Asian
3.988600E-01
AfricanAmerican-vs-Asian
6.025800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
4.551800E-01
Normal-vs-Female
4.054400E-01
Male-vs-Female
8.285000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
5.387200E-01
Normal-vs-Age(41-60Yrs)
7.109400E-01
Normal-vs-Age(61-80Yrs)
3.236000E-01
Normal-vs-Age(81-100Yrs)
4.749600E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
4.403200E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
8.905000E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
6.017600E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
2.672400E-02
Age(41-60Yrs)-vs-Age(81-100Yrs)
5.021800E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
5.792600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
3.901800E-01
Normal-vs-Daily Drinker
7.147000E-01
Normal-vs-Weekly Drinker
5.039200E-01
Normal-vs-Occasional Drinker
4.352000E-01
Normal-vs-Social Drinker
7.867200E-01
Non Drinker-vs-Daily Drinker
3.935000E-01
Non Drinker-vs-Weekly Drinker
7.783800E-01
Non Drinker-vs-Occasional Drinker
6.616400E-01
Non Drinker-vs-Social Drinker
2.083000E-01
Daily Drinker-vs-Weekly Drinker
3.990600E-01
Daily Drinker-vs-Occasional Drinker
6.423200E-01
Daily Drinker-vs-Social Drinker
7.470600E-01
Weekly Drinker-vs-Occasional Drinker
5.876400E-01
Weekly Drinker-vs-Social Drinker
2.879400E-01
Occasional Drinker-vs-Social Drinker
3.444200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
9.825800E-01
Normal-vs-Grade 2
9.715800E-01
Normal-vs-Grade 3
9.580400E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
8.707000E-01
Grade 1-vs-Grade 3
4.198800E-01
Grade 1-vs-Grade 4
9.825800E-01
Grade 2-vs-Grade 3
1.272830E-01
Grade 2-vs-Grade 4
9.715800E-01
Grade 3-vs-Grade 4
9.580400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
3.049800E-01
Normal-vs-NonDiabetic
4.524200E-01
Diabetic-vs-NonDiabetic
2.230800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
3.767000E-01
Normal-vs-NoPancreatitis
3.541000E-01
Pancreatitis-vs-NoPancreatitis
8.207400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
4.338000E-01
Normal-vs-N1
4.466600E-01
N0-vs-N1
8.548000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
9.608400E-01
Normal-vs-TP53-NonMutant
7.247400E-01
TP53-Mutant-vs-TP53-NonMutant
1.424040E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
